Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1238631

Inadequate reporting quality of registered genome editing trials: an observational study


Jurić, Diana; Zlatin, Michael; Marušić, Ana
Inadequate reporting quality of registered genome editing trials: an observational study // Bmc medical research methodology, 22 (2022), 1; 131, 11 doi:10.1186/s12874-022-01574-0 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1238631 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Inadequate reporting quality of registered genome editing trials: an observational study

Autori
Jurić, Diana ; Zlatin, Michael ; Marušić, Ana

Izvornik
Bmc medical research methodology (1471-2288) 22 (2022), 1; 131, 11

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
clinical trials ; genome editing ; databases ; reporting

Sažetak
Background: To assess registration completeness and safety data of trials on human genome editing (HGE) reported in primary registries and published in journals, as HGE has safety and ethical problems, including the risk of undesirable and unpredictable outcomes. Registration transparency has not been evaluated for clinical trials using these novel and revolutionary techniques in human participants. Methods: Observational study of trials involving engineered site-specific nucleases and long-term follow-up observations, identified from the WHO ICTRP HGE Registry in November 2020 and two comprehensive reviews published in the same year. Registration and adverse events (AEs) information were collected from public registries and matching publications. Published data were extracted in May 2021. Results: Among 81 eligible trials, most were recruiting (51.9%) phase 1 trials (45.7%). Five trials were withdrawn. Most trials investigated CAR T cells therapies (45.7%) and used CRISPR/Cas9 (35.8%) ex vivo (88.9%). Among 12 trials with protocols both registered and published, eligibility criteria, sample size, and secondary outcome measures were consistently reported for less than a half. Three trials posted results in ClinicalTrials.gov, and one reported serious AEs. Conclusions: Incomplete registration and published data give emphasis to the need to increase the transparency of HGE trials. Further improvements in registration requirements, including phase 1 trials, and a more controlled publication procedure, are needed to augment the implementation of this promising technology.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Ana Marušić (autor)

Avatar Url Diana Gujinović (autor)

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Jurić, Diana; Zlatin, Michael; Marušić, Ana
Inadequate reporting quality of registered genome editing trials: an observational study // Bmc medical research methodology, 22 (2022), 1; 131, 11 doi:10.1186/s12874-022-01574-0 (međunarodna recenzija, članak, znanstveni)
Jurić, D., Zlatin, M. & Marušić, A. (2022) Inadequate reporting quality of registered genome editing trials: an observational study. Bmc medical research methodology, 22 (1), 131, 11 doi:10.1186/s12874-022-01574-0.
@article{article, author = {Juri\'{c}, Diana and Zlatin, Michael and Maru\v{s}i\'{c}, Ana}, year = {2022}, pages = {11}, DOI = {10.1186/s12874-022-01574-0}, chapter = {131}, keywords = {clinical trials, genome editing, databases, reporting}, journal = {Bmc medical research methodology}, doi = {10.1186/s12874-022-01574-0}, volume = {22}, number = {1}, issn = {1471-2288}, title = {Inadequate reporting quality of registered genome editing trials: an observational study}, keyword = {clinical trials, genome editing, databases, reporting}, chapternumber = {131} }
@article{article, author = {Juri\'{c}, Diana and Zlatin, Michael and Maru\v{s}i\'{c}, Ana}, year = {2022}, pages = {11}, DOI = {10.1186/s12874-022-01574-0}, chapter = {131}, keywords = {clinical trials, genome editing, databases, reporting}, journal = {Bmc medical research methodology}, doi = {10.1186/s12874-022-01574-0}, volume = {22}, number = {1}, issn = {1471-2288}, title = {Inadequate reporting quality of registered genome editing trials: an observational study}, keyword = {clinical trials, genome editing, databases, reporting}, chapternumber = {131} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font